Torsdag 18 Juni | 03:44:59 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-11-19 07:00 Kvartalsrapport 2026-Q3
2026-08-27 07:00 Kvartalsrapport 2026-Q2
2026-05-21 - X-dag ordinarie utdelning ELABS 0.00 NOK
2026-05-21 - Kvartalsrapport 2026-Q1
2026-05-20 - Årsstämma
2026-03-27 - Extra Bolagsstämma 2026
2026-02-26 - Bokslutskommuniké 2025
2025-11-20 - Kvartalsrapport 2025-Q3
2025-08-28 - Kvartalsrapport 2025-Q2
2025-05-22 - X-dag ordinarie utdelning ELABS 0.00 NOK
2025-05-22 - Kvartalsrapport 2025-Q1
2025-05-21 - Årsstämma
2025-02-27 - Bokslutskommuniké 2024
2024-11-29 - Kvartalsrapport 2024-Q3
2024-07-12 - Kvartalsrapport 2024-Q2
2024-05-23 - X-dag ordinarie utdelning ELABS 0.00 NOK
2024-05-23 - Kvartalsrapport 2024-Q1
2024-05-22 - Årsstämma
2024-02-15 - Bokslutskommuniké 2023
2023-11-24 - Kvartalsrapport 2023-Q3
2023-07-13 - Kvartalsrapport 2023-Q2
2023-05-25 - Kvartalsrapport 2023-Q1
2023-05-24 - X-dag ordinarie utdelning ELABS 0.00 NOK
2023-05-23 - Årsstämma
2023-02-17 - Bokslutskommuniké 2022
2022-11-17 - Kvartalsrapport 2022-Q3
2022-07-14 - Kvartalsrapport 2022-Q2
2022-05-25 - Kvartalsrapport 2022-Q1
2022-05-23 - Årsstämma
2022-05-20 - X-dag ordinarie utdelning ELABS 0.00 NOK
2022-03-10 - Bokslutskommuniké 2021
2022-01-18 - Extra Bolagsstämma 2022
2021-11-10 - Kvartalsrapport 2021-Q3
2021-09-30 - Split ELABS 1:10
2021-09-24 - Extra Bolagsstämma 2021
2021-08-05 - Kvartalsrapport 2021-Q2
2021-05-12 - Kvartalsrapport 2021-Q1
2021-05-07 - X-dag ordinarie utdelning ELABS 0.00 NOK
2021-05-06 - Årsstämma
2021-03-10 - Bokslutskommuniké 2020

Beskrivning

LandNorge
ListaOslo Bors
SektorInformationsteknik
IndustriProgramvara
Elliptic Laboratories är verksamt inom teknikbranschen. Bolaget är specialiserat inom utveckling av sensorsystem. Programvaran är egenutvecklad och används huvudsakligen för mobila enheter samt applikationer. Kunderna består av små- och medelstora företagskunder verksamma i ett flertal sektorer. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster och rådgivning. Störst verksamhet återfinns inom den nordamerikanska marknaden.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-05-28 19:35:00

Oslo, Norway – Elliptic Labs (OSE: ELABS) announces that members of the Board of Directors have elected to receive part of their board remuneration in share options pursuant to the resolution approved at the Annual General Meeting held on 20 May 2026.

A total of 737,000 share options have been granted to members of the Board. Each option, when exercised, carries the right to acquire one share in the Company. The strike price for the options is NOK 3.08 per share, corresponding to the 10-day average volume-weighted share price prior to the Nomination Committee’s issuance of its recommendation to the 2026 AGM. The price of the options is based on the Black-Scholes model.

With this new grant, the total number of options outstanding in the Company now permits employees, management and members of the Board of Directors to potentially acquire up to 4,383,271 shares in aggregate, corresponding to approximately 3.5% of the total outstanding share capital.

Grant Details:

  • Svenn Tore Larsen (Chair) has been granted 263,000 share options. Following the grant, Larsen holds 417,000 share options in the Company.
  • Berit Svendsen (Member) has been granted 158,000 share options. Following the grant, Svendsen holds 251,000 share options in the Company.
  • Mikael Clement (Member) has been granted 158,000 share options. Following the grant, Clement holds 158,000 share options in the Company.
  • Svein Egil Nielsen (Member) has been granted 158,000 share options. Following the grant, Nielsen holds 251,000 share options in the Company.

Ingrid Leisner (Member) has elected not to receive share options and will instead receive the standard cash remuneration approved by the AGM. Board member Leisner holds 93,000 share options from previous grants.

Structure:
The options will have a vesting period until the date that is 12 months after the date of the 2026 AGM (“Vesting Date”) and can only be exercised between the Vesting Date and the date that is 24 months after the date of the 2026 AGM (“Expiry Date”). In the event a member of the Board resigns or is not re-elected prior to the Vesting Date, the options will lapse, except for a number of options representing the period served from the 2026 AGM until the date of resignation, pro rata in relation to the period from the 2026 AGM until the Vesting Date.